Trial ID or NCT#
This study uses a sequence of high-dose chemotherapy drugs and a stem cell transplant to treat multiple myeloma. The study is being performed to evaluate the efficacy and side effects of treatment. Specifically, the study is designed to reduce the risk of interstitial pneumonitis.
High-Dose Sequential Therapy and Single Autologous Transplantation for Multiple Myeloma
Contact us to find out if this trial is right for you.